Virologist and Former HHMI President Purnell Choppin Dies at 91
Virologist and Former HHMI President Purnell Choppin Dies at 91
Choppin drastically expanded the institute during his tenure in the 1980s and ’90s.
Virologist and Former HHMI President Purnell Choppin Dies at 91
Virologist and Former HHMI President Purnell Choppin Dies at 91

Choppin drastically expanded the institute during his tenure in the 1980s and ’90s.

Choppin drastically expanded the institute during his tenure in the 1980s and ’90s.

virology
Form Determines Function: Insights from Structural Biology
Form Determines Function: Insights from Structural Biology
The Scientist Creative Services Team | Jul 23, 2021
Researchers use diverse tools to analyze protein structures.
The Impact of Influenza
The Impact of Influenza
The Scientist Creative Services Team | Jul 13, 2021
Richard Webby and Edward Hutchinson discuss influenza viruses—the development of new strains, how they mediate virulence, and their threat to human society.
The Researchers Who Pivoted to COVID-19: One Year On
The Researchers Who Pivoted to COVID-19: One Year On
Shawna Williams | Jul 1, 2021
The Scientist checks in on scientists who switched gears to combat the pandemic.
Q&A: Human Challenge Studies of COVID-19 Underway in UK
Q&A: Human Challenge Studies of COVID-19 Underway in UK
Jef Akst | Jun 18, 2021
Researchers at Imperial College London and the University of Oxford are exposing healthy volunteers to SARS-CoV-2 for science.
Glucometers Detect SARS-CoV-2 Infection Within an Hour
Glucometers Detect SARS-CoV-2 Infection Within an Hour
Roni Dengler, PhD | Jun 14, 2021
Glucometers are easy-to-use, cheap, and highly scalable. And they are 100 percent accurate at detecting SARS-CoV-2.
Inhaled Antibody Fragments Protect Infected Animals Against COVID-19
Inhaled Antibody Fragments Protect Infected Animals Against COVID-19
Roni Dengler, PhD | Jun 14, 2021
Tiny but powerful nanobodies may be the innovation that snuffs out the pandemic.
Severe Symptoms of MIS-C Typically Clear Within Six Months: Study
Severe Symptoms of MIS-C Typically Clear Within Six Months: Study
Catherine Offord | May 26, 2021
Some children who experience the severe inflammatory condition after COVID-19 may continue to experience milder problems such as muscle weakness or anxiety even after that period, according to a small observational study in the UK.
CAR T Cells Derived from Stem Cells Target HIV Tissue Reservoirs in Monkeys
CAR T Cells Derived from Stem Cells Target HIV Tissue Reservoirs in Monkeys
Berly McCoy, PhD | May 25, 2021
Transplanted CAR stem cells persisted long term and showed multilineage engraftment in tissues that harbor HIV.
Coronavirus Mutations Could Muddle COVID-19 PCR Tests
Coronavirus Mutations Could Muddle COVID-19 PCR Tests
Jack J. Lee | May 17, 2021
Researchers find that SARS-CoV-2 variants can evade primer-probe sets and recommend that diagnostic assays include multiple targets for reliability.
Transforming Virology Research with Cryo-EM
Transforming Virology Research with Cryo-EM
The Scientist Creative Services Team | May 11, 2021
Explore what researchers can do with Cryo-EM
COVID-19 mRNA Vaccines Appear Effective Against Multiple Variants
COVID-19 mRNA Vaccines Appear Effective Against Multiple Variants
Lisa Winter | May 6, 2021
Data from three studies indicate that fully vaccinated patients are able to stave off severe disease from the B.1.1.7, B.1.351, and P.1 variants.
Random Plane Boarding Minimizes COVID-19 Risk: Study
Random Plane Boarding Minimizes COVID-19 Risk: Study
Christie Wilcox | Apr 27, 2021
A modeling study of boarding behavior finds filling the plane from back to front extends the close contact time between passengers and therefore increases the risks posed by air travel.
Highly Sensitive Viral Detection with the SARS-CoV-2 NGS Assay
Highly Sensitive Viral Detection with the SARS-CoV-2 NGS Assay
The Scientist Staff | Apr 15, 2021
Kristin Butcher and Mara Cuoto-Rodriguez discuss the development of a nucleic acid hybridization capture-based assay to detect and identify novel SARS-CoV-2 variants.
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Jef Akst | Apr 9, 2021
Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.
Fast-Tracking COVID-19 Research
Fast-Tracking COVID-19 Research
The Scientist Creative Services Team in collaboration with Sartorius Corporation | Mar 17, 2021
Identifying molecular targets for SARS-CoV-2 therapeutics.
UPDATED
Ebola Outbreak in Guinea Originated from Past Epidemic
Ebola Outbreak in Guinea Originated from Past Epidemic
Asher Jones | Mar 15, 2021
Genetic analyses suggest that the virus came from a patient who survived the 2013–2016 West African outbreak.
Sex Differences in COVID-19
Sex Differences in COVID-19
The Scientist Staff | Mar 9, 2021
Sabra Klein, a biologist at Johns Hopkins Bloomberg School of Public Health, describes how SARS-CoV-2 affects men and women differently.
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Asher Jones | Mar 3, 2021
Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.
Variant Found in Brazil Could Evade Immunity from Past Infection
Variant Found in Brazil Could Evade Immunity from Past Infection
Lisa Winter | Mar 2, 2021
The P.1 variant, which has also been detected in five US states, could be responsible for cases of reinfection, according to a preprint.